EP1553868A1 - Apparatus for monitoring a patient - Google Patents

Apparatus for monitoring a patient

Info

Publication number
EP1553868A1
EP1553868A1 EP03753745A EP03753745A EP1553868A1 EP 1553868 A1 EP1553868 A1 EP 1553868A1 EP 03753745 A EP03753745 A EP 03753745A EP 03753745 A EP03753745 A EP 03753745A EP 1553868 A1 EP1553868 A1 EP 1553868A1
Authority
EP
European Patent Office
Prior art keywords
sensor device
analyser
sample
sensor
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP03753745A
Other languages
German (de)
French (fr)
Inventor
Barry Colin Crane
Alasdair Allan Mackenzie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Diametrics Medical Ltd
Original Assignee
Diametrics Medical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diametrics Medical Ltd filed Critical Diametrics Medical Ltd
Publication of EP1553868A1 publication Critical patent/EP1553868A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14539—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring pH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
    • A61B5/1459—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters invasive, e.g. introduced into the body by a catheter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1495—Calibrating or testing of in-vivo probes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/49—Blood
    • G01N33/4925—Blood measuring blood gas content, e.g. O2, CO2, HCO3

Definitions

  • the invention relates to an apparatus for monitoring the condition of a patient and to a monitoring method.
  • monitoring of certain parameters for example, blood gases - in particular oxygen partial pressure (p0 2 ) , carbon dioxide partial pressure (pC0 2 ) and pH - in bodily fluids
  • p0 2 oxygen partial pressure
  • pC0 2 carbon dioxide partial pressure
  • pH - in bodily fluids can give useful information regarding the condition of a patient.
  • monitoring is carried out in many cases by taking samples from the patient at intervals and analysing each sample.
  • so-called "continuous" monitoring devices for example the device commercially available under the trade mark PARATREND, which have an elongate sensor portion which can be introduced into a blood vessel through a previously introduced catheter.
  • the concentration of oxygen and carbon dioxide and the pH is monitored by optical sensing means housed in the sensor portion.
  • “Substantially continuously” as used herein is to be understood to include monitoring non-continuously at relatively high frequency, for example, at intervals of no more than five minutes, for example, not more than one minute, especially intervals of not more than one second.
  • Continuous monitoring devices may, with suitable modification, be inserted into soft tissue or introduced into organs for determining analytes in the tissue or organ in question.
  • the continuous monitoring devices may require calibration before use. After insertion into the patient, re-calibration is not feasible, and the monitoring device may be susceptible to drift away from the calibration values. Whilst any such drift tends to be small, it is not unusual for the monitoring device to remain in the patient for a number of days so that, cumulatively, the drift may become material with the result that data measured a number of days after introduction of the device cannot reliably be compared with data measured shortly after its introduction.
  • the present invention provides an apparatus for monitoring a patient, comprising an invasive optical sensor device for monitoring substantially continuously a parameter relating to a bodily fluid of the patient and an analyser device in communication with the sensor device for analysing a sample of bodily fluid withdrawn from the patient to derive information relating to the sample of bodily fluid.
  • Sensor device refers below to "sensor device” as referring to a sensor device for monitoring substantially continuously a parameter relating to a bodily fluid of the patient.
  • the word ⁇ invasive' is to be understood as meaning that at least a part of the sensor device is, in use, inserted into the body of the patient and is in contact with the bodily fluid.
  • the sensor device will normally include a sensor probe for insertion into the patient, interrogation means for interrogating the sensor probe and data collection means for collecting data from the sensor probe.
  • the interrogation means and/or the data collection means may be remote from the sensor probe, for example, in an interface unit or in a monitor upon which data can be displayed, or may be incorporated into the sensor probe structure.
  • the interrogation means and data collection means will be in communication with the sensor probe by any suitable means.
  • the apparatus of the invention enables both substantially continuous monitoring of a parameter by the sensor device and intermittent ex vivo or in vitro analysis of samples of bodily fluid by the analyser device to be carried out, providing information from both sources for use by a clinician.
  • the information relating to the sample of body fluid is advantageously the parameter monitored by the sensor device.
  • the apparatus is so arranged that information derived by the analyser device can be compared with measurements made by the sensor device.
  • the data from the sensor device and the analyser device may be supplied to a common display device, at which each set of data is displayed and can be compared visually. If desired, the data from the sensor device and the analyser device may be supplied to a common processing means in which the comparison of the data is effected.
  • measurements can be made by the sensor device essentially in real-time, measurements relating to a sample withdrawn from the patient will normally be available only after a delay, typically after the sample has been sent to a laboratory for analysis .
  • the measurements made by the sensor device are recorded and information derived by the analyser device relating to a sample of bodily fluid can be compared with a measurement made by the sensor device substantially contemporaneously with the withdrawal of that sample.
  • This enables a more reliable comparison to be made between the two sets of data, which may be particularly important where the parameter is changing at a material rate, for example because of a deterioration in the patient's condition.
  • the apparatus is such that comparison of the data from the analyser device with data from the sensor device can be used for calibration and/or re-calibration of the sensor device.
  • a first calibration of the sensor device may be carried out based on comparison of readings from the sensor device, in situ in the patient, with readings from the analyser device, it may in practice be preferable for an initial calibration of the sensor device to be carried out before insertion of the sensor device into the patient, subsequent re-calibrations then being based on a comparison of readings from the sensor device in situ in the patient with readings from the analyser device.
  • the apparatus is arranged to effect automatic calibration and/or re-calibration of the sensor device when a difference between a value determined by the sensor device and a value determined by the analyser device in relation to the sample of bodily fluid is calculated in said comparison to be outside a target tolerance range.
  • the arrangement may .instead be such that the data from the sensor device and the data from the analyser device is displayed and the calibration and/or re-calibration can be effected manually.
  • the apparatus may comprise an analyser device arranged to withdraw samples at predetermined intervals.
  • the apparatus may be arranged to withdraw samples at, for example, regular intervals.
  • the apparatus may be arranged such that the samples can be withdrawn through a sensor probe of the sensor device .
  • the sensor device and the analyser device may be suitable for determining any parameter suitable for providing information about patient condition.
  • the sensor device can measure two or more parameters and the analyser device can measure at least two parameters that are also measured by the sensor device.
  • the sensor device and the analyser device are each able to determine at least one parameter selected from p0 2 , pC0 2 , pH, Na + , K + , lactate, and glucose.
  • the sensor device comprises at least sensing devices for determining p0 2 , pC0 2 and pH.
  • the sensor device may also include a temperature measuring device, for example, a thermocouple.
  • the sensor device is suitable for insertion into, and the analyser device is suitable for analysing blood withdrawn from, a blood vessel.
  • the sensor device may be, for example, an optical sensor device of the type which detects changes in the spectroscopic characteristics of a sensor substance which is contained in the sensor device, typically in the sensor probe.
  • the substance is in contact with the bodily fluid (or is separated from it by a barrier which is permeable to the analyte to be sensed so that the analyte can diffuse from the fluid to the sensor substance) and reacts reversibly with the analyte in such a way that changes in concentration of the analyte in the bodily fluid cause corresponding changes in the spectroscopic characteristics of the sensor substance.
  • the changes may be, for example, changes in the absorption or in the fluorescence characteristics of the sensor substance.
  • the invention also provides a method of calibrating an invasive optical sensor device comprising monitoring substantially continuously a parameter relating to a bodily fluid of the patient using the sensor device, analysing a sample of that bodily fluid in an analyser device, comparing an analysis result obtained by the sensor device with an analysis result obtained by the analyser device, and effecting adjustment of data relating to the sensor device in dependence upon the comparison .
  • the adjustment may be effected automatically.
  • the adjustment may be effected manually.
  • the history of the substantially continuous measurements is recorded, and the comparison is effected with the value of the substantially continuous measurement that obtained at the time of taking of the sample.
  • samples of the bodily fluid are withdrawn and analysed at intervals.
  • the samples are withdrawn and analysed at predetermined intervals. More advantageously, samples are withdrawn and analysed at regular intervals.
  • At least one parameter selected from p0 2 , pC0 2/ pH is measured by the sensor device and the analyser device.
  • the monitoring of blood gas concentrations can be of particular relevance in patients undergoing critical care, for example post-operatively or following trauma.
  • detection of a reduction in the oxygen concentration and/or an increase in the carbon dioxide concentration in bodily fluids can give early determination of the condition of the patient enabling appropriate treatment to be implemented promptly.
  • the analysis of the samples ex vivo means that there is a delay between sampling and provision of the results, and the results merely provide a "snapshot" view of the patient's condition.
  • Fig. 1 is a block diagram of an apparatus according to the invention.
  • Fig. 2 is a flow diagram of a patient monitoring method using the apparatus of Fig. 1.
  • the apparatus comprises a sensor device having a sensor probe 1 which is suitable for insertion into a blood vessel of a patient to be monitored.
  • the sensor device may be a Paratrend (trade mark) continuous blood monitor manufactured by Diametrics Medical Limited, which is suitable for monitoring oxygen (p0 2 ) and carbon dioxide (pC0 2 ) concentration and pH in blood.
  • the sensor device is calibrated, for example, by placing the sensor probe 1 into a solution of known p0 2 , pC0 2 , and pH.
  • the sensor further includes a sensor interface 2.
  • the sensor probe 1 is connected via a sensor interface device 2 to a monitor 3, on which the measured values can be displayed in graphical or numerical form.
  • the apparatus also comprises an analyser device 4 for analysing samples of blood withdrawn from the patient.
  • an analyser device may be an IRMA (trade mark) device made by Diametrics Medical Inc.
  • the IRMA is a blood analysis system in which a sample of blood can be withdrawn from the patient and placed in a cartridge which is arranged to be received in a sample space in a blood analyser where automatic analysis of the sample for various blood analytes can be carried out in vitro, including determination of p0 2 , pC0 2 , and pH.
  • the analyser device 4 is connected via an analyser interface device 5 to a monitor 3, which in Fig. 1 is the same monitor as that to which the sensor interface device 2 is connected.
  • the sensor device comprising probe 1 and sensor interface 2, and the analyser device 4 are in communication with each other via the monitor 3, which may contain a processor for processing data received from the sensor device 1 and the analyser device 4.
  • the apparatus comprises a sensor clock 6 in communication with the sensor device 1.
  • the sensor clock 6 is shown in Fig. 1 as being associated with interface device 2 but may instead be integrated into the sensor probe 1 or monitor 3.
  • the apparatus also has an analyser clock 7 in communication with the analyser device 4.
  • the analyser clock 7 may be associated with interface device 5 as shown in Fig. 1, but may instead be integrated into the analyser device 4 or monitor 3.
  • the sensor probe 1 of the sensor device 1 is introduced into a blood vessel of the patient, for example, a radial or femoral artery.
  • the control device (the control device may be within one of, or distributed throughout, the sensor device 2, monitor 3 and analyser 4) enables synchronisation of the sensor clock 6 and the analyser clock 7.
  • the sensor device comprising probe 1 and sensor interface device 2, commences substantially continuous collection of data relating to the analytes of interest in the blood and the data is passed via sensor interface unit 2 to monitor 3 where, after processing, it is displayed on the monitor 3.
  • the control device registers readings from the sensor clock 6 and those readings are used to "time-stamp" the readings from the sensor device 1.
  • a sample of blood is withdrawn from the patient and immediately placed in the analyser device 4.
  • the analyser clock 7 records the time of sample introduction as the sampling time.
  • the analyser device 4 then proceeds to analyse the blood sample for various parameters, including at least one parameter that is being determined substantially continuously by the sensor device.
  • the measured values of the parameter or parameters and the sampling time are supplied to the control device.
  • the control device scans the previously recorded data from the sensor probe 1 and sensor clock 6 and identifies, based on the sensor clock data, sensor readings which had been recorded substantially contemporaneously with the sampling time. The sensor readings are compared with the measured values from the analyser device for the same parameters.
  • the comparison may be carried out by the control device and a report displayed on monitor 3 or, if preferred, the relevant data from the sensor device 1 and the analyser device 4 may be displayed separately for visual comparison by a clinician.
  • the sensor device automatically re-calibrates the sensor probe 1 based on the analyser values and data collection continues. If the difference from the analyser is smaller than the target value, data collection may continue without re- calibration.
  • sampling and correlation steps are then repeated at appropriate intervals.
  • the measurement taken from a device such as the Paratrend device mentioned above will be affected only by a slow drift.
  • the cumulative drift over time may be material and conventional re-calibration cannot be carried out whilst the sensor probe is in place in the patient.
  • An appropriate regime for correlation of the sensor device readings with analyser device readings will depend on the particular condition of the patient.
  • One form of regimen is set out in detail in Fig. 2, and includes the following steps:
  • Step I Negotiation between sensor device and analyser device 4 to establish relative time.
  • Step Ila Continuous data collection and data time- stamping by sensor device.
  • Step lib Time-stamping by analyser device 4 of sample taken from patient and evaluation of sample by analyser device 4.
  • Step III Results of sample analysis and sample time-stamp passed by analyser device 4 to sensor device 1.
  • Step IV Processor instructed to effect correlation of data from analyser device 4 with data being collected continuously by sensor device.
  • Step Va Correlation of data from sensor device 1 with data from analyser device 4.
  • Step Vb Analyser device 4 awaiting acknowledgement from sensor device 1.
  • Step VI Sensor device confirming successful correlation to analyser device 4.
  • sample withdrawal and analysis and correlation of the sensor device (if appropriate) based on analyser device readings may be carried out intermittently at regular intervals, for example, four- hourly or eight-hourly.
  • sample withdrawal and analysis and correlation of the sensor device (if appropriate) may be carried out intermittently at the convenience of the clinician, for example, to coincide with routine ward visits.
  • samples are withdrawn manually by an attendant and placed in the analyser device 4.
  • the analyser device may be arranged automatically to withdraw samples and analyse them at predetermined intervals.
  • time-stamped data from the sensor device and the time-stamped data from the analyser 4 to be displayed separately, for example on separate monitors, and for the clinician to determine whether re- calibration is appropriate and initiate appropriate adjustment of the sensor device.

Abstract

The invention provides an apparatus for monitoring a patient, comprising an invasive optical sensor device for monitoring substantially continuously a parameter relating to a bodily fluid of the patient, for example, p02, pCO2 and/or pH, and an analyser device in communication with the sensor device for analysing a sample of bodily fluid withdrawn from the patient to derive information relating to the sample of bodily fluid. The information may be used for calibrating the sensor device.

Description

Apparatus for monitoring a patient
The invention relates to an apparatus for monitoring the condition of a patient and to a monitoring method. It is known that monitoring of certain parameters, for example, blood gases - in particular oxygen partial pressure (p02) , carbon dioxide partial pressure (pC02) and pH - in bodily fluids can give useful information regarding the condition of a patient. In practice, such monitoring is carried out in many cases by taking samples from the patient at intervals and analysing each sample. Also known are so-called "continuous" monitoring devices, for example the device commercially available under the trade mark PARATREND, which have an elongate sensor portion which can be introduced into a blood vessel through a previously introduced catheter. The concentration of oxygen and carbon dioxide and the pH is monitored by optical sensing means housed in the sensor portion. Those devices enable the parameters to be monitored substantially continuously, so that attendant medical staff will become aware, without the delays inherent in sampling and sample analysis, of any significant change in patient condition. "Substantially continuously" as used herein is to be understood to include monitoring non-continuously at relatively high frequency, for example, at intervals of no more than five minutes, for example, not more than one minute, especially intervals of not more than one second. Continuous monitoring devices may, with suitable modification, be inserted into soft tissue or introduced into organs for determining analytes in the tissue or organ in question.
The continuous monitoring devices may require calibration before use. After insertion into the patient, re-calibration is not feasible, and the monitoring device may be susceptible to drift away from the calibration values. Whilst any such drift tends to be small, it is not unusual for the monitoring device to remain in the patient for a number of days so that, cumulatively, the drift may become material with the result that data measured a number of days after introduction of the device cannot reliably be compared with data measured shortly after its introduction.
The present invention provides an apparatus for monitoring a patient, comprising an invasive optical sensor device for monitoring substantially continuously a parameter relating to a bodily fluid of the patient and an analyser device in communication with the sensor device for analysing a sample of bodily fluid withdrawn from the patient to derive information relating to the sample of bodily fluid. References below to "sensor device" are to be understood as referring to a sensor device for monitoring substantially continuously a parameter relating to a bodily fluid of the patient. The word ^invasive' is to be understood as meaning that at least a part of the sensor device is, in use, inserted into the body of the patient and is in contact with the bodily fluid. The sensor device will normally include a sensor probe for insertion into the patient, interrogation means for interrogating the sensor probe and data collection means for collecting data from the sensor probe. The interrogation means and/or the data collection means may be remote from the sensor probe, for example, in an interface unit or in a monitor upon which data can be displayed, or may be incorporated into the sensor probe structure. The interrogation means and data collection means will be in communication with the sensor probe by any suitable means.
The apparatus of the invention enables both substantially continuous monitoring of a parameter by the sensor device and intermittent ex vivo or in vitro analysis of samples of bodily fluid by the analyser device to be carried out, providing information from both sources for use by a clinician.
The information relating to the sample of body fluid is advantageously the parameter monitored by the sensor device. Advantageously, the apparatus is so arranged that information derived by the analyser device can be compared with measurements made by the sensor device. The data from the sensor device and the analyser device may be supplied to a common display device, at which each set of data is displayed and can be compared visually. If desired, the data from the sensor device and the analyser device may be supplied to a common processing means in which the comparison of the data is effected.
Whereas, in practice, measurements can be made by the sensor device essentially in real-time, measurements relating to a sample withdrawn from the patient will normally be available only after a delay, typically after the sample has been sent to a laboratory for analysis .
Advantageously, the measurements made by the sensor device are recorded and information derived by the analyser device relating to a sample of bodily fluid can be compared with a measurement made by the sensor device substantially contemporaneously with the withdrawal of that sample. This enables a more reliable comparison to be made between the two sets of data, which may be particularly important where the parameter is changing at a material rate, for example because of a deterioration in the patient's condition.
Advantageously, the apparatus is such that comparison of the data from the analyser device with data from the sensor device can be used for calibration and/or re-calibration of the sensor device. Whilst in principle, a first calibration of the sensor device may be carried out based on comparison of readings from the sensor device, in situ in the patient, with readings from the analyser device, it may in practice be preferable for an initial calibration of the sensor device to be carried out before insertion of the sensor device into the patient, subsequent re-calibrations then being based on a comparison of readings from the sensor device in situ in the patient with readings from the analyser device. Advantageously, the apparatus is arranged to effect automatic calibration and/or re-calibration of the sensor device when a difference between a value determined by the sensor device and a value determined by the analyser device in relation to the sample of bodily fluid is calculated in said comparison to be outside a target tolerance range. The arrangement may .instead be such that the data from the sensor device and the data from the analyser device is displayed and the calibration and/or re-calibration can be effected manually.
The apparatus may comprise an analyser device arranged to withdraw samples at predetermined intervals. The apparatus may be arranged to withdraw samples at, for example, regular intervals. The apparatus may be arranged such that the samples can be withdrawn through a sensor probe of the sensor device . The sensor device and the analyser device may be suitable for determining any parameter suitable for providing information about patient condition. Preferably the sensor device can measure two or more parameters and the analyser device can measure at least two parameters that are also measured by the sensor device. Advantageously, the sensor device and the analyser device are each able to determine at least one parameter selected from p02, pC02, pH, Na+, K+, lactate, and glucose. Preferably the sensor device comprises at least sensing devices for determining p02, pC02 and pH. The sensor device may also include a temperature measuring device, for example, a thermocouple. Advantageously, the sensor device is suitable for insertion into, and the analyser device is suitable for analysing blood withdrawn from, a blood vessel.
The sensor device may be, for example, an optical sensor device of the type which detects changes in the spectroscopic characteristics of a sensor substance which is contained in the sensor device, typically in the sensor probe. In use, the substance is in contact with the bodily fluid (or is separated from it by a barrier which is permeable to the analyte to be sensed so that the analyte can diffuse from the fluid to the sensor substance) and reacts reversibly with the analyte in such a way that changes in concentration of the analyte in the bodily fluid cause corresponding changes in the spectroscopic characteristics of the sensor substance. The changes may be, for example, changes in the absorption or in the fluorescence characteristics of the sensor substance. The invention also provides a method of calibrating an invasive optical sensor device comprising monitoring substantially continuously a parameter relating to a bodily fluid of the patient using the sensor device, analysing a sample of that bodily fluid in an analyser device, comparing an analysis result obtained by the sensor device with an analysis result obtained by the analyser device, and effecting adjustment of data relating to the sensor device in dependence upon the comparison . The adjustment may be effected automatically. The adjustment may be effected manually.
Preferably the history of the substantially continuous measurements is recorded, and the comparison is effected with the value of the substantially continuous measurement that obtained at the time of taking of the sample.
Preferably, samples of the bodily fluid are withdrawn and analysed at intervals. Advantageously, the samples are withdrawn and analysed at predetermined intervals. More advantageously, samples are withdrawn and analysed at regular intervals.
Preferably, at least one parameter selected from p02, pC02/ pH is measured by the sensor device and the analyser device.
The monitoring of blood gas concentrations can be of particular relevance in patients undergoing critical care, for example post-operatively or following trauma. In such patients, detection of a reduction in the oxygen concentration and/or an increase in the carbon dioxide concentration in bodily fluids can give early determination of the condition of the patient enabling appropriate treatment to be implemented promptly. Even where samples are taken frequently, the analysis of the samples ex vivo means that there is a delay between sampling and provision of the results, and the results merely provide a "snapshot" view of the patient's condition.
One illustrative embodiment of the invention will now be described in detail, with reference to the accompanying drawings in which:
Fig. 1 is a block diagram of an apparatus according to the invention; and
Fig. 2 is a flow diagram of a patient monitoring method using the apparatus of Fig. 1.
The apparatus comprises a sensor device having a sensor probe 1 which is suitable for insertion into a blood vessel of a patient to be monitored. For example, the sensor device may be a Paratrend (trade mark) continuous blood monitor manufactured by Diametrics Medical Limited, which is suitable for monitoring oxygen (p02) and carbon dioxide (pC02) concentration and pH in blood. The sensor device is calibrated, for example, by placing the sensor probe 1 into a solution of known p02, pC02, and pH. The sensor further includes a sensor interface 2. The sensor probe 1 is connected via a sensor interface device 2 to a monitor 3, on which the measured values can be displayed in graphical or numerical form. The apparatus also comprises an analyser device 4 for analysing samples of blood withdrawn from the patient. For example, an analyser device may be an IRMA (trade mark) device made by Diametrics Medical Inc. The IRMA is a blood analysis system in which a sample of blood can be withdrawn from the patient and placed in a cartridge which is arranged to be received in a sample space in a blood analyser where automatic analysis of the sample for various blood analytes can be carried out in vitro, including determination of p02, pC02, and pH. The analyser device 4 is connected via an analyser interface device 5 to a monitor 3, which in Fig. 1 is the same monitor as that to which the sensor interface device 2 is connected.
In the embodiment of Fig. 1 the sensor device, comprising probe 1 and sensor interface 2, and the analyser device 4 are in communication with each other via the monitor 3, which may contain a processor for processing data received from the sensor device 1 and the analyser device 4. The apparatus comprises a sensor clock 6 in communication with the sensor device 1. The sensor clock 6 is shown in Fig. 1 as being associated with interface device 2 but may instead be integrated into the sensor probe 1 or monitor 3. The apparatus also has an analyser clock 7 in communication with the analyser device 4. The analyser clock 7 may be associated with interface device 5 as shown in Fig. 1, but may instead be integrated into the analyser device 4 or monitor 3.
In use, after calibration, the sensor probe 1 of the sensor device 1 is introduced into a blood vessel of the patient, for example, a radial or femoral artery. The control device (the control device may be within one of, or distributed throughout, the sensor device 2, monitor 3 and analyser 4) enables synchronisation of the sensor clock 6 and the analyser clock 7. The sensor device comprising probe 1 and sensor interface device 2, commences substantially continuous collection of data relating to the analytes of interest in the blood and the data is passed via sensor interface unit 2 to monitor 3 where, after processing, it is displayed on the monitor 3. The control device registers readings from the sensor clock 6 and those readings are used to "time-stamp" the readings from the sensor device 1. After substantially continuous monitoring for a suitable interval, for example, 30 minutes to 8 hours, a sample of blood is withdrawn from the patient and immediately placed in the analyser device 4. The analyser clock 7 records the time of sample introduction as the sampling time. The analyser device 4 then proceeds to analyse the blood sample for various parameters, including at least one parameter that is being determined substantially continuously by the sensor device. Following analysis of the sample by the analyser device 4, the measured values of the parameter or parameters and the sampling time are supplied to the control device. The control device scans the previously recorded data from the sensor probe 1 and sensor clock 6 and identifies, based on the sensor clock data, sensor readings which had been recorded substantially contemporaneously with the sampling time. The sensor readings are compared with the measured values from the analyser device for the same parameters. The comparison may be carried out by the control device and a report displayed on monitor 3 or, if preferred, the relevant data from the sensor device 1 and the analyser device 4 may be displayed separately for visual comparison by a clinician. ι If the comparison shows that the analyser data varies from contemporaneous sensor data by more than a desired amount, for example, by more than 5% of the value measured by the sensor, the sensor device automatically re-calibrates the sensor probe 1 based on the analyser values and data collection continues. If the difference from the analyser is smaller than the target value, data collection may continue without re- calibration.
The sampling and correlation steps are then repeated at appropriate intervals.
In practice, the measurement taken from a device such as the Paratrend device mentioned above will be affected only by a slow drift. Where such devices are used for relatively long periods in a patient, for example from 3 to 30 days, the cumulative drift over time may be material and conventional re-calibration cannot be carried out whilst the sensor probe is in place in the patient. An appropriate regime for correlation of the sensor device readings with analyser device readings will depend on the particular condition of the patient. One form of regimen is set out in detail in Fig. 2, and includes the following steps:
Step I - Negotiation between sensor device and analyser device 4 to establish relative time.
Step Ila - Continuous data collection and data time- stamping by sensor device.
Step lib - Time-stamping by analyser device 4 of sample taken from patient and evaluation of sample by analyser device 4.
Step III - Results of sample analysis and sample time-stamp passed by analyser device 4 to sensor device 1. Step IV - Processor instructed to effect correlation of data from analyser device 4 with data being collected continuously by sensor device.
Step Va - Correlation of data from sensor device 1 with data from analyser device 4. Step Vb - Analyser device 4 awaiting acknowledgement from sensor device 1.
Step VI - Sensor device confirming successful correlation to analyser device 4.
The above steps can then be repeated at intervals as appropriate.
In one regimen sample withdrawal and analysis and correlation of the sensor device (if appropriate) based on analyser device readings may be carried out intermittently at regular intervals, for example, four- hourly or eight-hourly. In another suitable regimen sample withdrawal and analysis and correlation of the sensor device (if appropriate) may be carried out intermittently at the convenience of the clinician, for example, to coincide with routine ward visits. In the arrangement described above, samples are withdrawn manually by an attendant and placed in the analyser device 4. If preferred, the analyser device may be arranged automatically to withdraw samples and analyse them at predetermined intervals.
Further, it is also within the ambit of the invention for the time-stamped data from the sensor device and the time-stamped data from the analyser 4 to be displayed separately, for example on separate monitors, and for the clinician to determine whether re- calibration is appropriate and initiate appropriate adjustment of the sensor device.

Claims

Claims
1. An apparatus for monitoring a patient, comprising an invasive optical sensor device for monitoring substantially continuously a parameter relating to a bodily fluid of the patient and an analyser device in communication with the sensor device for analysing a sample of bodily fluid withdrawn from the patient to derive information relating to the sample of bodily fluid.
2. An apparatus according to claim 1, in which the information relating to the sample of bodily fluid is the parameter monitored by the sensor device.
3. An apparatus according to claim 1 or claim 2, the apparatus being so arranged that information derived by the analyser device can be compared with measurements made by the sensor device.
4. An apparatus according to claim 3, in which the measurements made by the sensor device are recorded and information derived by the analyser relating to a sample can be compared with a measurement made by the sensor device substantially contemporaneously with the withdrawal of that sample.
5. An apparatus according to claim 3 or claim 4, in which comparison of the data from the analyser device with data from the sensor device can be used for calibration and/or re-calibration of the sensor device.
6. An apparatus according to claim 5, which is arranged to effect automatic calibration and/or re-calibration of the sensor device when a difference between a value determined by the sensor device and a value determined by the analyser device is calculated on said comparison to be outside a target tolerance range.
7. An apparatus according to claim 5, in which the data from the sensor device and the data from the analyser device is displayed and the calibration and/or re- calibration can be effected manually.
8. An apparatus according to any one of claims 1 to 7, which comprises a withdrawal device for withdrawing a sample for analysis by the analyser device.
9. An apparatus according to claim 8, which is arranged to withdraw samples at predetermined intervals.
10. An apparatus according to claim 8 or claim 9, which is arranged to withdraw samples at regular intervals.
11. An apparatus according to any one of claims 8 to 10, in which the samples can be withdrawn through a probe of the sensor device.
12. An apparatus according to any one of claims 1 to 11, in which the probe of the sensor device is suitable for insertion into, and the analyser is arranged for analysis of blood from, a blood vessel.
13. An apparatus according to any one of claims 1 to 12, in which the sensor device is an optical sensor device of the type which detects changes in the spectroscopic characteristics of a sensor substance which is contained in the sensor device.
14. An apparatus according to any one of claims 1 to 13, in which the sensor device and the analyser device are each arranged to determine a plurality of parameters.
15. An apparatus according to any one of claims 1 to 14, in which the analyser device and the sensor device are each able to monitor concentration of at least one blood analyte.
16. An apparatus according to claim 15, in which the analyser device and the sensor device are each able to monitor at least one blood gas.
17. An apparatus for monitoring a patient substantially as described herein with reference to and as illustrated by Fig. 1.
18. A method of calibrating and/or recalibrating an invasive optical sensor device comprising monitoring substantially continuously a parameter relating to a bodily fluid of the patient using the sensor device, analysing a sample of that bodily fluid in an analyser device, comparing an analysis result obtained by the sensor device with an analysis result obtained by the analyser device, and effecting adjustment of data relating to the sensor device in dependence upon the comparison.
19. A method according to claim 18, in which said adjustment is effected automatically.
20. A method according to claim 18, in which said adjustment is effected manually.
21. A method according to any one of claims 18 to 20, in which the history of the substantially continuous measurements is recorded, and the comparison is effected with the value of the substantially continuous measurement that obtained at the time of taking of the sample.
22. A method according to any one of claims 18 to 20, in which samples of the bodily fluid are withdrawn and analysed at intervals.
23. A method according to claim 22, in which the samples are withdrawn and analysed at predetermined intervals.
24. A method according to claim 22 or claim 23, in which samples are withdrawn and analysed at regular intervals.
25. A method according to any one of claims 18 to 24, in which at least one parameter selected from p02, pC02, pH is measured by the sensor device and the analyser device .
26. A method of calibrating an invasive optical sensor device substantially as described herein.
EP03753745A 2002-10-07 2003-10-07 Apparatus for monitoring a patient Withdrawn EP1553868A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0223222A GB0223222D0 (en) 2002-10-07 2002-10-07 Apparatus and method for monitoring a patient
GB0223222 2002-10-07
PCT/GB2003/004331 WO2004030533A1 (en) 2002-10-07 2003-10-07 Apparatus for monitoring a patient

Publications (1)

Publication Number Publication Date
EP1553868A1 true EP1553868A1 (en) 2005-07-20

Family

ID=9945423

Family Applications (1)

Application Number Title Priority Date Filing Date
EP03753745A Withdrawn EP1553868A1 (en) 2002-10-07 2003-10-07 Apparatus for monitoring a patient

Country Status (4)

Country Link
EP (1) EP1553868A1 (en)
AU (1) AU2003271907A1 (en)
GB (1) GB0223222D0 (en)
WO (1) WO2004030533A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4340457A (en) * 1980-01-28 1982-07-20 Kater John A R Ion selective electrodes
US5234835A (en) * 1991-09-26 1993-08-10 C.R. Bard, Inc. Precalibrated fiber optic sensing method
US6558321B1 (en) * 1997-03-04 2003-05-06 Dexcom, Inc. Systems and methods for remote monitoring and modulation of medical devices
US5944660A (en) * 1997-07-08 1999-08-31 Optical Sensors Incorporated Disposable cartridge assembly with optional integrated temperature control system, and systems containing same

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2004030533A1 *

Also Published As

Publication number Publication date
GB0223222D0 (en) 2002-11-13
WO2004030533A1 (en) 2004-04-15
AU2003271907A1 (en) 2004-04-23

Similar Documents

Publication Publication Date Title
US5068536A (en) Method for providing custom calibration for near infrared instruments for measurement of blood glucose
CA2504661C (en) Method and device for monitoring an analyte concentration in the living body of a human or animal
AU674474B2 (en) An analytical system for monitoring a substance to be analyzed in patient-blood
US20080312859A1 (en) Method of Calibrating a System for Measuring the Concentration of Substances in Body and an Apparatus for Exercising the Method
RU2749187C2 (en) Computer-implemented method and portable apparatus for analysis of glucose control data indicating glucose level in bodily fluid
NO880891L (en) PROCEDURE AND APPARATUS FOR MEASURING OR DETECTING THE CONCENTRATION OF A SUBSTANCE.
JP4531983B2 (en) Attribute compensation for analyte detection and / or continuous monitoring
CZ20021820A3 (en) Method for automatic monitoring analyte concentration by making use of least invasive devices
US6064896A (en) Non-invasive measurement of blood glucose using instruments that have less precise detection capability
US20200383645A1 (en) Method and device for analyzing continuously monitored physiological measurement values of a user
US10010274B2 (en) Systems, devices and methods for in situ calibration of implantable sensors
US5507289A (en) System and method to diagnose bacterial growth
Brinkert et al. Lactate measurements in critically ill patients with a hand-held analyser
US5304495A (en) Method for determining flush interference in measurement of chemical and physical parameters with indwelling probe
Martin et al. Performance and use of paracorporeal fiber optic blood gas sensors
US8092384B2 (en) System and method for continuous detection of an analyte in bloodstream
WO2017023500A1 (en) Apparatus and method for the noninvasive monitoring of nitric oxide and other blood gases
ES2753356T3 (en) A procedure and device for determining a patient's body fluid glucose level, and a computer program product
US5477854A (en) System and method to monitor gastrointestinal Helicobacter pylori infection
EP1553868A1 (en) Apparatus for monitoring a patient
Roupie Equipment review: Continuous assessment of arterial blood gases
US20160073940A1 (en) Systems, Devices And Methods For In Situ Calibration Of Implantable Sensors
Slingerland et al. Evaluation of portable blood glucose meters. Problems and recommendations
Baines et al. Comparison of venous, capillary and interstitial blood glucose data measured during hyperbaric oxygen treatment from patients with diabetes mellitus
Karis et al. Clinical evaluation of the Edwards Laboratories and Oximetrix mixed venous oxygen saturation catheters

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20050504

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK

DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20060503